IGC Pharma (IGC) Institutional Ownership $0.36 +0.03 (+9.78%) Closing price 08/14/2025 03:59 PM EasternExtended Trading$0.36 +0.01 (+1.68%) As of 04:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsBuy This Stock Institutional Ownership Changes (13F Filings) for IGC Pharma (NYSEMKT:IGC)CurrentInstitutional OwnershipPercentage3.87%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$228.71KNumber ofInstitutional Sellers(last 12 months)0 Get IGC Insider Trade Alerts Want to know when executives and insiders are buying or selling IGC Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IGC Institutional Buying and Selling by Quarter IGC Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Squarepoint Ops LLC125,966$42K0.0%N/A0.163% 2/14/2025 Northern Trust Corp113,407$38K0.0%+59.7%0.146% 2/12/2025 Geode Capital Management LLC669,685$225K0.0%+19.0%0.865% 11/20/2024 Virtu Financial LLC123,060$53K0.0%+164.7%0.159% 11/16/2024 Geode Capital Management LLC562,969$240K0.0%+31.0%0.744% 10/29/2024 Fullcircle Wealth LLC103,443$42K0.0%N/A0.137% (Data available from 1/1/2016 forward) IGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IGC shares? During the previous two years, the following institutional investors and hedge funds held shares of IGC Pharma shares: Geode Capital Management LLC ($225K), Virtu Financial LLC ($53K), Squarepoint Ops LLC ($42K), and Fullcircle Wealth LLC ($42K), Northern Trust Corp ($38K).Learn more on IGC Pharma's institutional investors. What percentage of IGC Pharma's stock is owned by institutional investors? 3.87% of IGC Pharma's stock is owned by institutional investors. Learn more on IGC's institutional investor holdings. Which institutional investors have been buying IGC Pharma's stock? The following institutional investors have purchased IGC Pharma's stock in the last 24 months: Geode Capital Management LLC ($239.86K), Squarepoint Ops LLC ($125.97K), Fullcircle Wealth LLC ($103.44K), Virtu Financial LLC ($76.56K), and Northern Trust Corp ($42.38K). How much institutional buying is happening at IGC Pharma? Institutional investors have bought a total of 588,210 shares in the last 24 months. This purchase volume represents approximately $228.71K in transactions. Related Companies Avalo Therapeutics Institutional Ownership Scilex Institutional Ownership Genelux Institutional Ownership ALT5 Sigma Institutional Ownership IO Biotech Institutional Ownership Protara Therapeutics Institutional Ownership Immuneering Institutional Ownership Cassava Sciences Institutional Ownership OKYO Pharma Institutional Ownership Corbus Pharmaceuticals Institutional Ownership This page (NYSEMKT:IGC) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access